Raul Rodriguez Ramirez, MD | |
606 W Arch Ave, Ste. A, Searcy, AR 72143-5206 | |
(501) 279-0211 | |
(501) 279-0213 |
Full Name | Raul Rodriguez Ramirez |
---|---|
Gender | Male |
Speciality | Internal Medicine |
Experience | 54 Years |
Location | 606 W Arch Ave, Searcy, Arkansas |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1720081789 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RP1001X | Internal Medicine - Pulmonary Disease | R4544 (Arkansas) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Gentiva Hospice | Little rock, AR | Hospice |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Primary Care 360 | 4183050842 | 3 |
News Archive
Adults from 30 to 60 years old, especially those from lower socioeconomic backgrounds, aren't consuming the daily recommended levels of fruits and vegetables. Quebecers, however, eat more of nature's produce than their fellow Canadians.
Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic imaging, today announced that new data for BMS747158, the company's novel drug candidate in clinical development as a Positron Emission Tomography (PET) perfusion imaging agent, will be featured in an oral presentation at the American College of Cardiology 59th Annual Scientific Session taking place March 14-16, 2010 in Atlanta.
Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., today announced that they have initiated a Phase I clinical trial of AGS-16M8F an antibody-drug conjugate (ADC) that is being developed for the treatment of metastatic renal cancer. An ADC uses the specific binding properties of an antibody to target a toxin in tumor cells, resulting in selective tumor cell killing.
A scientist on the Florida campus of The Scripps Research Institute has received funding from the Philadelphia-based Margaret Q. Landenberger Research Foundation.
Actavis plc today confirmed that the Company has received a complete response letter from the U.S. Food and Drug Administration (FDA) for its New Drug Application (NDA) for the fixed-dose combination (FDC) of nebivolol and valsartan for the treatment of hypertension.
› Verified 1 days ago
Entity Name | St Vincent Medical Group |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1134176480 PECOS PAC ID: 5698758803 Enrollment ID: O20040622000224 |
News Archive
Adults from 30 to 60 years old, especially those from lower socioeconomic backgrounds, aren't consuming the daily recommended levels of fruits and vegetables. Quebecers, however, eat more of nature's produce than their fellow Canadians.
Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic imaging, today announced that new data for BMS747158, the company's novel drug candidate in clinical development as a Positron Emission Tomography (PET) perfusion imaging agent, will be featured in an oral presentation at the American College of Cardiology 59th Annual Scientific Session taking place March 14-16, 2010 in Atlanta.
Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., today announced that they have initiated a Phase I clinical trial of AGS-16M8F an antibody-drug conjugate (ADC) that is being developed for the treatment of metastatic renal cancer. An ADC uses the specific binding properties of an antibody to target a toxin in tumor cells, resulting in selective tumor cell killing.
A scientist on the Florida campus of The Scripps Research Institute has received funding from the Philadelphia-based Margaret Q. Landenberger Research Foundation.
Actavis plc today confirmed that the Company has received a complete response letter from the U.S. Food and Drug Administration (FDA) for its New Drug Application (NDA) for the fixed-dose combination (FDC) of nebivolol and valsartan for the treatment of hypertension.
› Verified 1 days ago
Entity Name | Primary Care 360 |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1124678586 PECOS PAC ID: 4183050842 Enrollment ID: O20200129001002 |
News Archive
Adults from 30 to 60 years old, especially those from lower socioeconomic backgrounds, aren't consuming the daily recommended levels of fruits and vegetables. Quebecers, however, eat more of nature's produce than their fellow Canadians.
Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic imaging, today announced that new data for BMS747158, the company's novel drug candidate in clinical development as a Positron Emission Tomography (PET) perfusion imaging agent, will be featured in an oral presentation at the American College of Cardiology 59th Annual Scientific Session taking place March 14-16, 2010 in Atlanta.
Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., today announced that they have initiated a Phase I clinical trial of AGS-16M8F an antibody-drug conjugate (ADC) that is being developed for the treatment of metastatic renal cancer. An ADC uses the specific binding properties of an antibody to target a toxin in tumor cells, resulting in selective tumor cell killing.
A scientist on the Florida campus of The Scripps Research Institute has received funding from the Philadelphia-based Margaret Q. Landenberger Research Foundation.
Actavis plc today confirmed that the Company has received a complete response letter from the U.S. Food and Drug Administration (FDA) for its New Drug Application (NDA) for the fixed-dose combination (FDC) of nebivolol and valsartan for the treatment of hypertension.
› Verified 1 days ago
Entity Name | American Hope And Health Clinic Associates Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1538781208 PECOS PAC ID: 0547674293 Enrollment ID: O20210121000277 |
News Archive
Adults from 30 to 60 years old, especially those from lower socioeconomic backgrounds, aren't consuming the daily recommended levels of fruits and vegetables. Quebecers, however, eat more of nature's produce than their fellow Canadians.
Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic imaging, today announced that new data for BMS747158, the company's novel drug candidate in clinical development as a Positron Emission Tomography (PET) perfusion imaging agent, will be featured in an oral presentation at the American College of Cardiology 59th Annual Scientific Session taking place March 14-16, 2010 in Atlanta.
Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., today announced that they have initiated a Phase I clinical trial of AGS-16M8F an antibody-drug conjugate (ADC) that is being developed for the treatment of metastatic renal cancer. An ADC uses the specific binding properties of an antibody to target a toxin in tumor cells, resulting in selective tumor cell killing.
A scientist on the Florida campus of The Scripps Research Institute has received funding from the Philadelphia-based Margaret Q. Landenberger Research Foundation.
Actavis plc today confirmed that the Company has received a complete response letter from the U.S. Food and Drug Administration (FDA) for its New Drug Application (NDA) for the fixed-dose combination (FDC) of nebivolol and valsartan for the treatment of hypertension.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Raul Rodriguez Ramirez, MD 606 W Arch Ave, Ste A, Searcy, AR 72143-5206 Ph: (501) 279-0211 | Raul Rodriguez Ramirez, MD 606 W Arch Ave, Ste. A, Searcy, AR 72143-5206 Ph: (501) 279-0211 |
News Archive
Adults from 30 to 60 years old, especially those from lower socioeconomic backgrounds, aren't consuming the daily recommended levels of fruits and vegetables. Quebecers, however, eat more of nature's produce than their fellow Canadians.
Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic imaging, today announced that new data for BMS747158, the company's novel drug candidate in clinical development as a Positron Emission Tomography (PET) perfusion imaging agent, will be featured in an oral presentation at the American College of Cardiology 59th Annual Scientific Session taking place March 14-16, 2010 in Atlanta.
Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., today announced that they have initiated a Phase I clinical trial of AGS-16M8F an antibody-drug conjugate (ADC) that is being developed for the treatment of metastatic renal cancer. An ADC uses the specific binding properties of an antibody to target a toxin in tumor cells, resulting in selective tumor cell killing.
A scientist on the Florida campus of The Scripps Research Institute has received funding from the Philadelphia-based Margaret Q. Landenberger Research Foundation.
Actavis plc today confirmed that the Company has received a complete response letter from the U.S. Food and Drug Administration (FDA) for its New Drug Application (NDA) for the fixed-dose combination (FDC) of nebivolol and valsartan for the treatment of hypertension.
› Verified 1 days ago
Stephen R. Toothaker, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 415 Rodgers Dr Ste A, Searcy, AR 72143 Phone: 501-278-3100 | |
Dr. Robert R Camferdam, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 403 S Poplar St Ste D, Searcy, AR 72143 Phone: 501-279-7077 Fax: 501-279-3970 | |
Mitzi Ann Washington, MD Pulmonary Disease Medicare: May Accept Medicare Assignments Practice Location: 400 S Main St, Suite 200, Searcy, AR 72143 Phone: 501-279-0502 Fax: 501-279-0506 | |
John C Henderson, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 2900 Hawkins Dr, Searcy, AR 72143 Phone: 501-278-2808 Fax: 501-278-3001 | |
David Mark Evans, M. D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 711 Santa Fe Dr, Searcy, AR 72143 Phone: 501-279-9393 | |
Ahmad Radi Abdelhadi Tarawneh, M.D Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2900 Hawkins Dr, Searcy, AR 72143 Phone: 501-278-2800 | |
Katherine J Durham, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 711 Santa Fe Dr, Searcy, AR 72143 Phone: 501-279-9393 |